Results 51 to 60 of about 84,797 (237)

Activity of meropenem, against Gram-positive bacteria [PDF]

open access: yes, 2017
A new carbapenem antibiotic, meropenem, was shown to be active against a large number of Gram-positive bacteria. The drug inhibited penicillinase-positive and -negative, methicillin-susceptible staphylococci equally well.
Kayser, F. H.   +3 more
core  

Extension of Sous Vide Preservation of Red Deer Meat With Ocimum basilicum Essential Oil: A Study on Antibacterial Effectiveness Against Listeria monocytogenes

open access: yesFlavour and Fragrance Journal, EarlyView.
A study on the preservative and antibacterial potential of Ocimum basilicum EO against Listeria monocytogenes. ABSTRACT Pathogens responsible for foodborne illnesses remain a major public health concern, particularly with the increasing preference for minimally processed and ready‐to‐eat products.
Miroslava Kačániová   +10 more
wiley   +1 more source

Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K-pneumoniae

open access: yes, 2010
Meropenem heteroresistance was investigated in six apparently meropenem-susceptible, Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) clinical isolates, compared with that in carbapenemase-negative, meropenem-susceptible ...
Poulou, A.   +6 more
core   +3 more sources

Metagenomic and culture‐based insights into host and plasmid contexts of high‐risk ARGs in poultry farm environments

open access: yesiMetaOmics, EarlyView.
Shotgun metagenomics and culture‐based isolate genomics revealed position‐associated high‐risk antibiotic resistance genes (ARGs) signals across poultry manure piles and surrounding soils. Culture‐confirmed Enterobacteriaceae and IncHI2A‐related blaNDM‐5 plasmid backgrounds further highlight priority host‐ARG‐plasmid contexts for farm antimicrobial ...
Yaling Wang   +5 more
wiley   +1 more source

MUTANT PREVENTION CONCENTRATION ANTIMIKROBA MEROPENEM PADA BAKTERI ACINETOBACTER BAUMANNII SENSITIF DAN RESISTEN MEROPENEM DARI ISOLAT PASIEN RAWAT INAP INTENSIF [PDF]

open access: yes, 2016
Acinetobacter baumannii merupakan bakteri oportunistik yang berimplikasi terhadap peningkatan infeksi nosokomial yang parah. Meropenem umumnya digunakan untuk pengobatan infeksi organisme ini pada pasien sakit parah.
DEWI RETNONINGSIH, NIM011082202
core   +1 more source

Microbacterium spp. peritonitis in patients undergoing peritoneal dialysis: a single-center experience and literature review

open access: yesFrontiers in Medicine, 2023
IntroductionPeritoneal dialysis-related peritonitis (PDRP) caused by Microbacterium spp. is very rare, with only 9 cases reported to date. In this study, we report the treatment experiences of 7 patients at our peritoneal dialysis center.MethodsWe ...
Xiao Yu   +8 more
doaj   +1 more source

Ceftazidime and meropenem MIC for engineered mutants.

open access: yes, 2023
Ceftazidime and meropenem MIC for engineered mutants.
Kay A. Ramsay (11856887)   +7 more
core   +1 more source

A preterm neonate with infantile liver failure syndrome 1 due to leucyl‐tRNA synthetase 1 gene (LARS1) mutations with a histopathologic phenotype of neonatal hemochromatosis

open access: yesJPGN Reports, EarlyView.
Abstract We report a case of a premature, growth‐restricted female infant with feeding intolerance and coagulopathy, treated initially for sepsis, who progressed to neonatal acute liver failure and end‐stage hepatic encephalopathy after a prolonged hospitalization with extensive diagnostic evaluation, and was found by autopsy to have histopathologic ...
Adrienne Bruder   +3 more
wiley   +1 more source

Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis

open access: yesAntibiotics
Background: Febrile neutropenia is a critical complication in patients with hematological malignancies; immediate initiation of empirical treatment with a broad-spectrum agent is the standard of care.
Leyla Yumrukaya   +6 more
doaj   +1 more source

Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains

open access: yes, 2023
The incidence of infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) is increasing worldwide, and very limited number of effective antibiotics are available for therapy.
Yaşar Nakipoğlu   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy